MAFLD/NASH animals compared to CVD group showed modifications in gene metabolic pathways implicated in lipid metabolic process, inflammatory response and insulin resistance; PR-PFD reversed these modifications. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.